Omalizumab in the treatment of eosinophilic granulomatosis with polyangiitis (EGPA): single-center experience in 18 cases

BACKGROUND: Data are limited regarding the effectiveness of omalizumab in patients with eosinophilic granulomatosis with polyangiitis (EGPA). Our aim was to evaluate the clinical and functional effectiveness of omalizumab in patients with EGPA in long-term follow-up. METHODS: This study was a retros...

Descripción completa

Detalles Bibliográficos
Autores principales: Celebi Sozener, Zeynep, Gorgulu, Begum, Mungan, Dilsad, Sin, Betul Ayse, Misirligil, Zeynep, Aydin, Omur, Bavbek, Sevim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276141/
https://www.ncbi.nlm.nih.gov/pubmed/30524647
http://dx.doi.org/10.1186/s40413-018-0217-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276141/
https://www.ncbi.nlm.nih.gov/pubmed/30524647
http://dx.doi.org/10.1186/s40413-018-0217-0

Ejemplares similares